Offers Invited
Hilco is delighted to offer for sale a company that has developed a version of tramadol tablets for use with dogs, to help manage pain. The company is a Marketing Authorisation Holder of Tramalgesic 50mg tablets, and the licence may be purchased via a sale of 100% of the shares, or a novation of the licence in isolation.
Should you require further information on the opportunity, please sign and
return the attached non-disclosure agreement (NDA) via email to [email protected].
No warranties, express or implied, are provided in relation to any information or statements made in connection to this opportunity. The information contained herein, and within the project dataroom, has not been verified by Hilco and prospective purchasers must undertake their own due diligence to satisfy themselves as to the accuracy of all such information and any statements made. Hilco’s full Terms and Conditions apply. Hilco acts as agent for the Vendor who offers for sale only such right, title and interest the Company possesses in the assets.
